ENB Therapeutics

ENB Therapeutics

Pharmaceutical Manufacturing 166 Fifth Ave 6 employees
Employees
6

ENB Therapeutics Overview

Headquarters
166 Fifth Ave
Phone Number
Available in AeroLeads
Website
enbpharma.com
Industry
Pharmaceutical Manufacturing
Employees
6
Founded
2015
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About ENB Therapeutics

ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.

ENB Therapeutics Contact Details

People in AeroLeads
1

ENB Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Tara Greco Elite Founding Member
View

Compare Similar Companies to ENB Therapeutics